OGIVRI
NDC 83257-004, trastuzumab-dkst, kit, from Biocon Biologics Inc..
- Product NDC
- 83257-004
- Status
- Listed
- Labeler
- Biocon Biologics Inc.
- Dosage form
- KIT
- Route
- —
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761074
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83257-004 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83257-004-12 | 83257000412 | 1 KIT in 1 CARTON (83257-004-12) * 20 mL in 1 VIAL, MULTI-DOSE (83257-003-11) * 20 mL in 1 VIAL (83257-002-11) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b6465b44-a6dd-f99c-d009-6851cf05169cMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=83257-004
Use it
Look up 83257-004 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83257-004 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83257-004. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.